Patients undergoing carotid endarterectomy were pretreated with low-dose, oral beta carotene to determine whether the carotenoid content of plaque could be increased in vivo. Beta carotene-treated patients had a 50-fold increase in their plaque beta carotene level from 0.066 to 3.3 ,ig beta carotene/g plaque. Microscopy and microspectrophotometry demonstrated that plaque from beta carotene-treated patients had higher carotenoid levels and higher absorption (450-500 nm) compared with control specimens, but normal media was unaffected. This demonstration of increased preferential absorption by plaque suggests that selective ablation of atherosclerotic plaque may be enhanced by pretreating patients with oral beta carotene. (Circulation 1988;78:338-344) L ' aser removal of the atherosclerotic plaques that obstruct arteries is now under clinical investigation. 1-4 The problem of confining laser radiation to plaque and avoiding ablation of nondiseased artery, however, has not been adequately addressed. Investigators are presently working on angioscopy, 5-7 fluorescence spectroscopy,8 raman scattering,9 and other techniques that discriminate between plaque and normal artery to improve their aiming capability. Another possibility is to use a laser emitting radiation that is preferentially absorbed by plaque. Ideally, this radiation would cause ablation when directed at plaque and have no deleterious effect when directed at normal tissues. In the 450-500 nm waveband, there is twofold preferential absorption in plaque because of yellow carotenoid chromophores in the plaque.'0 With the pulsed dye laser emitting 1or 8-msec pulses of radiation in this waveband, it is possible to ablate both soft and calcified plaque at fluences (energy/area) that are below the threshold for ablat-From the Wellman Laboratory (M.R.P. and G.M.L.) and the
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Patients undergoing carotid endarterectomy were pretreated with low-dose, oral beta carotene to determine whether the carotenoid content of plaque could be increased in vivo. Beta carotene-treated patients had a 50-fold increase in their plaque beta carotene level from 0.066 to 3.3 ,ig beta carotene/g plaque. Microscopy and microspectrophotometry demonstrated that plaque from beta carotene-treated patients had higher carotenoid levels and higher absorption (450-500 nm) compared with control specimens, but normal media was unaffected. This demonstration of increased preferential absorption by plaque suggests that selective ablation of atherosclerotic plaque may be enhanced by pretreating patients with oral beta carotene. (Circulation 1988;78:338-344) L ' aser removal of the atherosclerotic plaques that obstruct arteries is now under clinical investigation. [1] [2] [3] [4] The problem of confining laser radiation to plaque and avoiding ablation of nondiseased artery, however, has not been adequately addressed. Investigators are presently working on angioscopy, [5] [6] [7] fluorescence spectroscopy,8 raman scattering,9 and other techniques that discriminate between plaque and normal artery to improve their aiming capability. Another possibility is to use a laser emitting radiation that is preferentially absorbed by plaque. Ideally, this radiation would cause ablation when directed at plaque and have no deleterious effect when directed at normal tissues. In the 450-500 nm waveband, there is twofold preferential absorption in plaque because of yellow carotenoid chromophores in the plaque.'0 With the pulsed dye laser emitting 1or 8-msec pulses of radiation in this waveband, it is possible to ablate both soft and calcified plaque at fluences (energy/area) that are below the threshold for ablat-ing normal artery. 1 1-14Early clinical trials have been successful. "5 This specificity for plaque might be enhanced if the carotenoid content of the plaque could be increased.
Carotenoids are lipophilic yellow and red pigments found in vegetables and in lipid-rich human tissues (e.g., atherosclerotic plaque, subcutaneous fat, and stratum corneum'6). Blankenhorn has shown in a single patient that oral beta carotene increases the beta carotene content of xanthomas. '7 In the present study, the possibility of increasing the carotenoid content of atheromas by pretreating carotidendarterectomy patients with oral beta carotene is explored; then endarterectomy specimens are analyzed for beta carotene content. The effect on preferential absorption is further evaluated by light microscopy and microspectroscopic analysis of the carotid endarterectomy specimens.
Patients and Methods Patients
Ten patients scheduled for carotid endarterectomy volunteered (with the informed consent process) to take 180 mg beta carotene (Solatene, Hoffmann-LaRoche, Nutley, New Jersey) each day in three divided doses for periods varying from 8 to 41 days before their surgery. On the day of surgery, blood was taken for serum beta carotene determination, and the pills remaining in the bottle provided to the patient were counted to evaluate compliance. After surgery, each endarterectomy specimen was examined by a pathologist, washed in normal saline, and frozen at -700 C. Three of the patients had a previous carotid endarterectomy on the contralateral side without having taken beta carotene, and their specimens were saved (in an identical manner) to use as controls. An additional 16 patients underwent carotid endarterectomy without taking beta carotene; their specimens and serum were also saved at -70°C for use as controls. For all patients in the study, data on risk factors for atherosclerosis including age, sex, tobacco use, diabetes, hypertension, serum cholesterol, and serum triglycerides were obtained by chart review. The study was not randomized or blinded. Specimens of normal vascular tissue were not obtained because, in the carotid endarterectomy procedure, only abnormal tissue (by gross examination) is removed.
Carotenoid and Lipid Extraction
Lipids and carotenoids were extracted from all specimens with a method described previously.18 Endarterectomy specimens were first weighed and homogenized. Canthaxanthin, a carotenoid not normally found in human tissues, was added to five specimens as an internal control for evaluating the extraction yield. The homogenate was then saponified by adding 1 ml 6% KOH in absolute methanol and shaking in a 600 C water bath for 60 minutes. After saponification, the mixture was cooled to room temperature and extracted twice with 2 ml petroleum ether (b.p. 30-60°C; E-139, Fischer Scientific). The methanol and petroleum ether layers were allowed to separate (centrifuging when necessary). When necessary, a third ether extraction was performed. The petroleum ether extracts for each specimen were pooled. Serum was extracted by adding the 1 ml 6% KOH directly to 0.5 ml serum and then proceeding as with the plaque.
Beta Carotene Determination
The extracted carotenoids were further separated by a high-pressure liquid chromatography method described previously. 19 Ether was evaporated under nitrogen, and the specimens were resuspended in 1 ml methanol. After centrifuging at 2,000 rpm for 10 minutes to eliminate particulate matter, 220 ,ul of each specimen was injected (HPLC model 1090, Hewlett-Packard) onto a C-18, 5-,um, reverse-phase column (LC18, Supelco, Bellefonte, Pennsylvania) with an isocratic solvent (acetonitrile:methylenechloride:methanol, 70:20:10) flowing at 1.7 ml/min. The absolute amount of beta carotene was determined by integrating the area under the curve of absorbance at 450 nm versus time and comparing with the area obtained for a known amount of purified beta carotene. Extraction yield was determined as the ratio of canthaxanthin mass in the extract to the mass of canthaxanthin added to the
Statistical Analysis
Comparisons were made by a t test for dependent measures in the group of three patients who had two endarterectomy specimens each, one with and one without beta carotene pretreatment. These data were then pooled with the unpaired data of the appropriate type, and means of these data sets were compared with the t test for independent measures.
Microscopy
To evaluate where the beta carotene accumulated within the plaque, six specimens were examined microscopically. These included specimens from two patients who were studied both before and after beta carotene treatment and specimens from two patients who were studied only after beta carotene treatment. All specimens were prepared for histological analysis by embedding in optimal cutting temperature medium, sectioning by cryostat, and mounting without staining between coverslips with a single drop of aqueous mounting medium. They were then examined with conventional light microscopy and microspectrophotometry. On some specimens, additional sections were made with hematoxylin and eosin and pentachrome stains to examine the histological architecture in detail.
Microspectrophotometry
Absorption spectra were determined for all six sectioned specimens with a microspectrophotometry technique described previously.20 Light from a 50-W tungsten-halogen lamp was dispersed by a modified Czerny-Turner grating monochromator. This light transilluminated specimens sandwiched between coverslips on the stage of a microscope equipped with ultraviolet-transmitting apochromatic optics to permit measurements from 375 to 750 nm. The image of a pair of crossed slits was projected onto the plane of the specimen with a x 10 Zeiss ultrafluar UVF projection eyepiece and a Nikon UVF x40 dry objective. By adjusting the slits, illumination could be confined to spots as small as 2 ,um2. Light from this measuring beam was collected by a x 100 glycerol-immersion UVF objective that focused the slit image in the specimen plane onto an eyepiece or projected it, out of focus, onto a photomultiplier tube. An additional broad-field illumination source could be turned on to permit precise alignment of the measuring beam with the tissue structure of interest. The monochromator and photomultiplier tube with photon-counting electronics were interfaced to a computer for data collection and analysis. Data was collected by first scanning a blank area for calibration, then scanning the structure of interest, and finally calculating the optical density. Actual absorption coefficients could not be calculated because a reliable method of measuring specimen.
the thickness of frozen sections was not available. 
Results
All ten treated patients tolerated the beta carotene well and did not report any adverse effects.
Compliance was good with one patient averaging only 3.7 pills/day and the rest averaging 5-6 pills/ day (see Table 1 for a tabulation of the data). All patients on beta carotene had a serum beta carotene level that was more than 15 times the mean serum beta carotene level of the controls. The control group (consisting of 16 patients who did not take beta carotene pooled with three patients who were studied before and after beta carotene treatment) was well matched to the study group (consisting of seven patients studied only after taking beta carotene pooled with the three patients who were studied before and after beta carotene treatment) with similar age, sex distribution, smoking history, incidence of diabetes and hypertension, serum creati-nine, serum cholesterol, and serum triglycerides ( Table 2) .
At the time of surgery, the normal arterial tissue did not appear different in color in patients taking beta carotene. Some of the endarterectomy specimens from patients on beta carotene, however, did have a deeper yellow tone. Conventional light microscopy ( Figure 1 ) revealed faint yellow 0.1-10-,um diameter drops and streaks (Figure 1 , left) that were present diffusely throughout both of the control specimens that were examined microscopically. All four after-beta carotene treatment specimens that were examined microscopically had deeper yellow and yellow-orange coloring in fat drops in the atheroma (Figure 1, top right) . Those specimens also had orange crystalline objects (Figure 1 , bottom right) that appeared to be beta carotene that had come out of solution in the fat during freezing. 3.3+2.0 <0.001 *Three patients were studied before and after beta carotene treatment, seven patients were studied only after beta carotene treatment, and 16 patients were studied without beta carotene treatment; tNS, not significant.
Three of the after-beta carotene treatment specimens had a few layers of normal-appearing smooth muscle interspersed with elastic tissue and collagen at the outermost edge. This normal tissue did not contain any yellow pigment.
Microspectrophotometry (Figure 2 ) of the normal smooth muscle on the three specimens on which it was found always revealed spectra consistent with myoglobin with peaks at 410 nm and 530-600 nm. Spectra of plaque were more variable. In both control patients studied microscopically, the plaque spectra consisted of a broad peak at 410 nm with a shoulder at 430-530 nm consistent with absorption by endogenous carotenoids. The magnitude of this shoulder varied from one location to another but was always greatest in fat droplets and least in regions of plaque in-between fat droplets. Spectra from the yellow fat drops in after-beta carotene treatment specimens were dominated by beta carotene absorption with a peak at 450 nm. The optical densities of the dark orange crystals seen in Figures lB and ID were too high to be resolved by the microspectrophotometer used in the present study.
Determination of beta carotene levels by highpressure liquid chromatography was performed on all specimens of plaque and serum. A representative chromatogram is shown in Figure 3 . For all specimens, the carotenoids separated into multiple components, each having the characteristic three peaked absorption spectra of carotenoids. These major carotenoid components varied in peak area from one individual to the next but always eluted at the same times. These differences in peak areas presumably reflect variations in diet among the subjects. Beta carotene eluted at 12-13 minutes as a single distinct peak. The average of the beta carotene levels in plaque and serum, calculated from the areas of the beta carotene peaks, are shown in Table 1 . For plaque, the average beta carotene levels in control and after-beta carotene treatment specimens were 0.066-0.07 and 3.3 ± 0.07 ,ug/g of plaque, respectively. This 50-fold increase in beta carotene content was highly significant with p<0.OOl. If just the group of three patients studied before and after beta carotene treatment is considered, there was an average increase in the plaque beta carotene content by a factor of 31 (p = 0.011).
Extraction yield was 35%. Discussion
Confining the effects of laser radiation to the atheromatous material obstructing arteries has been the major challenge of laser endarterectomy. Recently, selective ablation of plaque has been demonstrated in vitro and clinically with 465-490-nm laser pulses that are absorbed by carotenoid pigments in the plaque.1015 This study of human carotid endarterectomy specimens on patients treated with beta carotene demonstrates a 50-fold increase in the plaque beta carotene content. Although normal vascular tissue was not available from these patients in sufficient amounts to measure its beta carotene content (with the high-pressure liquid chromatography technique), its appearance at surgery and microscopic analysis suggests that the beta carotene accumulated preferentially in the plaque. Preferential accumulation of beta carotene in plaque is also consistent with the high fat content of plaque relative to normal vascular tissue and the high affinity that carotenoids have for fat as compared with water.21 This increased carotenoid content in the plaque may enhance the selective ablative effect of 450-500-nm laser radiation, potentially making laser endarterectomy simpler, safer, and more effective. Increasing light absorption in plaque also decreases the penetration depth of laser radiation into the plaque. This enables the laser pulse to remove plaque in smaller increments, which may result in a smoother surface for the remaining unablated tissue as well as smaller ablation products. Because the Microspectrophotometry of carotid plaques from the same patient taken before and after beta carotene treatment. Before treatment (dashed line), the plaque spectra consists of a broad peakfrom 350 to 600 nm that probably represents a combination of absorption from heme pigments (with peaks at 410 nm and 540-600 nm) and carotenoids (with peaks at 430-530 nm). After beta carotene treatment, the plaque spectra (solid thin line) is dominated by a beta carotene-like spectra with a peak at 450 nm. Also after beta carotene treatment, normal smooth muscle underlying the plaque (dotted line) shows peaks at 410 nm and 540-600 nm, consistent with myoglobin absorption, but no significant carotenoid absorption. laser energy is distributed over a smaller volume, less intensity would be required, reducing the potential for damage to normal artery and delivery system optics. Fluorescence detection systems used to discriminate plaque from normal artery may be enhanced if they analyze or excite plaque in the waveband of carotenoid absorption. Detection schemes based on raman or resonance raman scattering from carotene may also be enhanced. Other lasers emitting radiation in this waveband, such as argon ion, may also have a more desirable ablative effect if patients are pretreated with carotenoids. Carotenoids also have some absorption in the ultraviolet spectrum, which might enhance the effect of shorter wavelength lasers such as the excimer. Because beta carotene is not the only carotenoid and carotenoids are not the only absorbers of 450-500-nm radiation in plaque, increasing beta carotene levels by a factor of 50 does not generate a 50-fold increase in plaque absorption. The noticeable change in the color of plaque indicates that the increased beta carotene content is optically significant. If beta carotene is estimated to account for about 6% of plaque carotenoid absorption at 480 nm, its 50-fold increase translates into an approximate doubling of plaque absorption to give about 4:1 preferential absorption to plaque. This is consistent with the spectral changes shown in Figure 2 .
The 50-fold increase in plaque beta carotene achieved here with low-dose oral beta carotene for a limited time underestimates the degree of carotenoid loading that could be achieved if the treatment = 1e t-BETA CAROTENE- RETENTION TIME (MINUTES) FIGURE 3. Representative high-pressure liquid chromatogram. Solid line shows the separation of carotenoids extracted from a single, after-beta carotene treatment specimen. There are multiple carotenoid peaks. Beta carotene, eluting at 12.5 minutes, is a single distinct peak. Dashed line indicates the magnitude of the beta carotene peak from a specimen taken from the same patient before beta carotene treatment. Difference in areas ofthe beta carotene peaks represent the increase in the plaque beta carotene content with oral beta carotene loading.
were optimized. The beta carotene content of lipidrich stratum corneum in erythropoietic protoporphyria patients being treated with similar or higher doses of beta carotene reaches a peak after 6 weeks of treatment. The 180 mg/day used in the present study is safe and could be increased considerably. Intravenous administration, which has been described in animals,22 may enhance both the speed and magnitude of beta carotene partitioning into plaque, particularly if the main limitation is intestinal or serum transport. There may also be other carotenoids (although beta carotene is the only one with U.S. Food and Drug Administration approval) that can accumulate in plaque more quickly, in larger amounts, or with greater extinction coefficients. Furthermore, use of other carotenoids that absorb at different wavelengths may permit manipulation of the peak absorption wavelength in plaque so as to match a laser emission line.
The beta carotene appears to accumulate in the plaque over the course of days to weeks. Determining the optimal dose and time for maximizing plaque beta carotene content will require a much larger patient population. The 57-fold increase in serum beta carotene compared with the smaller 50-fold increase in plaque beta carotene suggests that not all patients had time for the plaque beta carotene to equilibrate with the serum. The rapid accumulation of beta carotene compared with the time course of plaque formation, however, suggests that atheromas, although acellular, do evolve. The mechanism of beta carotene accumulation in plaque may be simple partitioning into lipids. This process is probably governed by the rate of transport of carotenoids in blood and rate of diffusion of carotenoids in the plaque.
To summarize, light absorption in atherosclerotic plaque is significantly and preferentially enhanced with oral beta carotene. This should improve the selective ablative effect of laser angioplasty and laser endarterectomy techniques with radiation in the 450-500-nm waveband.
